MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,049K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Fair value of vested restricted ...
Amortization of vendor advances
Amortization of intangible asset
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable and accrued exp...
Payment of deferred offering cos...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Debt discount amortization
-
-
0
0
Fair value of common shares issued in connection with the conversion of accounts payable
-
-
0
0
Fair value of warrants issued in connection with convertible notes payable
-
-
0
0
Gain on settlement of accounts payable
-
-
0
-
Net loss
-1,388
-1,654
-1,365
-1,398
Vendor advances
-
-
0
0
Amortization of intangible asset
22
40
40
40
Amortization of vendor advances
213
220
212
660
Fair value of vested restricted stock units
259
259
259
70
Prepaid expenses and other current assets
-7
92
27
-64
Accounts payable and accrued expenses
-125
191
-203
-274
Proceeds from common stock issued for cash in connection with the closing of the initial public offering
-
-
0
0
Net cash used in operating activities
-1,012
-1,036
-1,084
-838
Proceeds from notes payable - officers
-
-
0
0
Proceeds from the at the market (atm) offering
7
385
-
-
Payment of deferred offering costs
44
165
0
0
Proceeds from the sale and exercise of prefunded warrants
-
-
0
0
Proceeds from the equity line of credit
-
-
0
3,379
Net increase in cash and cash equivalents
-
-
-1,084
-
Net cash provided by financing activities
-37
220
0
3,379
Net increase (decrease) in cash and cash equivalents
-1,049
-816
-1,084
2,541
Cash and cash equivalents, beginning of period
3,675
4,491
5,575
1,272
Cash and cash equivalents, end of period
2,626
3,675
4,491
5,575
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash and cash...
-$1,049K
(-159.53%↓ Y/Y)
Fair value of vested
restricted stock units
$259K
(69.28%↑ Y/Y)
Amortization of vendor
advances
$213K
(-83.59%↓ Y/Y)
Amortization of intangible
asset
$22K
(-72.50%↓ Y/Y)
Prepaid expenses and
other current assets
-$7K
(-114.00%↓ Y/Y)
Proceeds from the at the
market (atm) offering
$7K
Net cash used in
operating activities
-$1,012K
(33.38%↑ Y/Y)
Net cash provided by
financing activities
-$37K
(-101.13%↓ Y/Y)
Canceled cashflow
$501K
Canceled cashflow
$7K
Net loss
-$1,388K
(48.29%↑ Y/Y)
Payment of deferred
offering costs
$44K
Accounts payable and
accrued expenses
-$125K
(60.44%↑ Y/Y)
Buy us a coffee
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)